AIManage Using an AI-driven CDS and Chatbot

AIManage is a newly registered GenAI-powered Clinical Decision Support (CDS) tool designed to support incretin mimetic medication management and dose titration optimization. The trial (NCT07546357) is registered with NIH via ClinicalTrials.gov and is being conducted at NYUH primary care and obesity medicine clinics. Phase 1 involves formative data collection for tool refinement, followed by a planned Phase 2 cluster randomized controlled trial.

Affected parties include clinical investigators, healthcare providers in primary care and obesity medicine, and trial sponsors. While this registry entry does not create direct compliance obligations, it signals increasing regulatory and institutional interest in AI-driven clinical decision support tools for metabolic and diabetes care. Organizations developing similar GenAI CDS tools should be aware that clinical validation pathways (including randomized controlled trials) are being pursued in academic health system settings.